Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 placebo-controlled study of intravenous ZW800-1 in healthy volunteers
NL-OMON45587Phase 1Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing ZW800-1 with Placebo (2 arms). Primary endpoints: Treatment-emergent adverse events, Clinical laboratory tests and 12 more. Started Feb 2017; status: active, not recruiting.
02
Drugs
nizaracianine triflutate
Beyond the preview
Go deeper on NL-OMON45587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45587.